Immunic share price logo

Immunic

NASDAQ: IMUX

$7.96

-0.68

(-7.87%)

as on

Immunic Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.75
    $8.87
    downward going graph

    2.64%

    Downside

    11.43%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.06
    $17.43
    downward going graph

    36.41%

    Downside

    118.97%

    Upside

    downward going graph

Immunic share price movements today

Previous Close
$8.64
Open
$8.73
Volume
585.8K
Market Cap
$117.9M
Day's Low - High
$7.75 - $8.87
52 Week Low - High
$5.06 - $17.43

Immunic Historical Returns

1 Month Return
-37.62 %
3 Month Return
-46.22 %
1 Year Return
-18.63 %
3 Year Return
-40.6 %
5 Year Return
-89.85 %

Immunic Stock Fundamentals & Key Indicators

Check Immunic market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$117.9M

EPS (TTM)

-4.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.81

Industry PE ratio

-3.02

PEG Ratio

-0.02

EBITDA

-111.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-157.89%

Immunic vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunic with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$117.9M-89.85%-1.810.00%0.00%
StrongBuy$44.1B609.62%-23.340.00%0.00%
Neutral$75.4B-44.29%-24.08-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Immunic Stock including INR - Dollar returns

The Immunic stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunic investment value today

Current value as on today

₹88,302

Returns

-₹11,698

(-11.7%)

Returns from Immunic Stock

-₹18,634 (-18.63%)

Dollar Impact

₹6,937 (+6.94%)

Analyst Recommendation on Immunic Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Immunic. Average target price of $43.09

Immunic Share Price Target

Get share price movements and forecasts by analysts on Immunic.

What analysts predicted

81.53%UPSIDE

Target Price

$43.09

Current Price

$7.96

Analyzed by

6 Analysts

High

$70

Target

$43.09

Low

$22

Immunic target price $43.09, a slight upside of 81.53% compared to current price of $7.96. According to 6 analysts rating.

Indian Investors' Interest in Immunic Stock

Search interest for Immunic Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Immunic Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
-
-
-
-
0
-
Operating Income
-23
-22
-25
-25
-26
-27
-25
-23
-33
-35
EBITDA
-29
-21
-24
-25
-25
-26
-25
-19
-32
-33
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-29
-21
-24
-25
-25
-26
-25
-19
-32
-34
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-29
-21
-24
-25
-25
-26
-25
-19
-32
-34
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunic Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
-52
-42
-37
-48
-91
-119
-99
-98
-103
EBITDA
-51
-15
-36
-48
-92
-86
-93
-100
-97
Interest Expense
-
-
0
-
-
1
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-41
-34
-44
-92
-120
-93
-100
-97
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
-52
-41
-34
-44
-92
-120
-93
-100
-97
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunic Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-29
-21
-24
-25
-25
-26
-25
-19
-32
-34
Operating Cash Flow
-23
-17
-20
-22
-21
-24
-20
-19
-17
-30
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
74
-
-
0
-
65
-
0
188
0
Change in Cash
50
-17
-20
-23
-21
41
-20
-19
171
-31

Immunic Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-52
-41
-34
-44
-92
-120
-93
-100
-97
Operating Cash Flow
-40
-43
-28
-46
-83
-65
-70
-84
-85
Investing Cash Flow
0
0
10
0
0
-9
9
0
0
Financing Cash Flow
37
0
34
144
42
95
1
74
65
Change in Cash
-3
-43
16
98
-40
19
-60
-11
-20

Global Institutional Holdings in Immunic

Check out the Institutions with significant holdings in Immunic.

Funds
Holdings
Fidelity Concord Street Trust
8.37%
Vanguard
4.09%
Michael Rockefeller
3.46%
iShares
0.32%
Kenneth Tropin
0.24%

Insights on Immunic

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 585.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 123.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IMUX stock has moved down by -14.8%

About Immunic

Immunic, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective oral immunotherapies for a range of chronic inflammatory and autoimmune conditions. Its primary investigational compound, IMU-838, has advanced to Phase 2 clinical trials, targeting relapsing-remitting multiple sclerosis (RRMS), inflammatory bowel disease (IBD), various other chronic inflammatory and autoimmune disorders, and also coronavirus disease. Additionally, the company is advancing IMU-935, which functions as an inverse agonist of RORγt, and IMU-856, designed to restore the intestinal barrier for patients afflicted with conditions like inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor-induced colitis, and other ailments affecting intestinal barrier integrity. The company's headquarters are located in New York, New York.
OrganisationImmunic
Headquarters1200 Avenue of the Americas, New York City, NY, 10036, US
IndustryBiotechnology
CEOErik Lundgren

Key Management of Immunic

Name

Title

Mr. Chitrang Davé

Chief Data & Digital Officer

Mr. Jason Tardio M.B.A.

COO & President

Mr. Erik Lundgren

CEO & Director

Mr. Patrick Walsh

Chief Business Officer

Dr. Michael A. Panzara M.D., M.P.H.

Chief Medical Officer

Mr. Werner Gladdines

Chief Development Officer

Mr. Glenn Whaley CPA

Chief Financial Officer

Dr. Hella Kohlhof

Co-Founder & Chief Scientific Officer

Ms. Jessica Breu

Vice President of Investor Relations & Communications

Mr. Inderpal Singh

General Counsel

FAQs

What is Immunic share price today?

Immunic share price today is $7.96 as on at the close of the market. Immunic share today touched a day high of $8.87 and a low of $7.75.

What is the 52 week high and 52 week low for Immunic share?

Immunic share touched a 52 week high of $17.43 on and a 52 week low of $5.06 on . Immunic stock price today i.e. is closed at $7.96,which is 54.33% down from its 52 week high and 57.25% up from its 52 week low.

What is Immunic's market capitalisation today?

Immunic market capitalisation is $0.00T as on .

How to invest in Immunic Stock (IMUX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunic on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Immunic Stock (IMUX) from India?

Indian investors can start investing in Immunic (IMUX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Immunic stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunic share’s latest price of $7.96 as on October 3, 2026 at 8:45 am IST, you will get 1.2563 shares of Immunic. Learn more about fractional shares .

What are the returns that Immunic has given to Indian investors in the last 5 years?

Immunic stock has given -89.85% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?